Delivery Order SPE2DB20D9354-SPE2DB25FX7W8
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $8.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On August 7, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, identified as 4569023499, is for 60 tablets of Xtandi 80 mg, an oncology medication. This award was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025. The order represents a single delivery under DMS...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under contract number 4568977608, calls for the supply of Xtandi 40 mg capsules in quantities of 120 units, with an ultimate completion date of August 4, 2025. This award was made on a firm fixed-price basis with no set-aside designation, leveraging...
- On September 5, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $43,113.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers the supply of 120 capsules of Xtandi 40 mg, an oncology medication used in cancer treatment. This award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, which is...
- On September 16, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,678.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order (4569478146) is for 120 tablets of Xtandi 40 mg, an oncology medication, with an ultimate completion date of September 17, 2025. This award was issued without a set-aside designation, leveraging DMS Pharmaceutical Group's competitive capabilities...
- On July 28, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4568915549, covers the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in the treatment of prostate cancer. This firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance to take place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $4,311.35 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 18, 2025, for 120 capsules of Xtandi 40 mg. The delivery order is not designated as a set-aside contract and carries an ultimate completion date of July 21, 2025. This award represents a single delivery transaction executed under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 14, 2025. This firm fixed-price delivery order covers the supply of Xtandi 80 mg tablets (60-count units), an oncology medication used in prostate cancer treatment. The award carries no set-aside designation and is scheduled for completion by August 15, 2025, with performance taking...
- On September 16, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, an oral medication used in oncology treatment. This firm fixed-price delivery order, issued without a set-aside designation, represents a single issuance under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the delivery of 120 capsules of the drug Xtandi (40 mg) to support the medical supply needs of military health facilities. The contract has an ultimate completion date of December 12, 2024. DMS Pharmaceutical Group Inc. holds a larger single-award...
- On June 2, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order calls for the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in prostate cancer treatment. This award was issued on a firm fixed-price basis with an ultimate completion date...